Loading stock data…
Loading stock data…
US$2.42
Get one email when GRCE crosses your level. Checked every 15 minutes during market hours.
▲ +0.01 (0.41%)up today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
51.1
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.01
Bullish momentumMACD above its signal line (-0.00).
50-day average
2.34
Price aboveShort-term trend reference.
200-day average
3.23
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Grace Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments. The company specializes in creating unique drug formulations and delivery systems to address unmet medical needs, particularly in the fields of neurology and rare diseases. Notable for its research and development efforts, Grace Therapeutics aims to enhance the effectiveness and patient experience of existing drugs by altering their formulations. This approach …
www.gracetx.com2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-07-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-18 | -0.2 | -0.08 | ✓ Beat |
| 2026-05-12 | 0.68 | 0.7 | ✓ Beat |
| 2026-02-27 | 0.18 | 0.21 | ✓ Beat |
| 2026-02-12 | -0.39 | -0.19 | ✓ Beat |
| 2025-11-13 | -0.34 | -0.08 | ✓ Beat |
| 2025-08-12 | -0.31 | -0.29 | ✓ Beat |
| 2025-06-23 | -0.4 | 0.14 | ✓ Beat |
| 2025-02-13 | -0.46 | -0.51 | ✗ Miss |
Companies in the same industry, via Finnhub